Muestra la distribución de su producción desde 2008 por disciplinas.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Institución | Fraunhofer Chile Res Fdn |
| WOS | #Pub |
|---|---|
| Microbiology | 16 |
| Biotechnology & Applied Microbiology | 5 |
| Plant Sciences | 5 |
| Integrative & Complementary Medicine | 4 |
| Energy & Fuels | 4 |
| Multidisciplinary Sciences | 4 |
| Biochemistry & Molecular Biology | 4 |
| Pharmacology & Pharmacy | 4 |
| Fisheries | 3 |
| Marine & Freshwater Biology | 3 |
| Veterinary Sciences | 3 |
| Biology | 3 |
| Chemistry, Medicinal | 3 |
| Chemistry, Analytical | 3 |
| Green & Sustainable Science & Technology | 2 |
| Food Science & Technology | 2 |
| Genetics & Heredity | 2 |
| Immunology | 2 |
| Engineering, Chemical | 2 |
| Neurosciences | 2 |
| Chemistry, Multidisciplinary | 2 |
| Clinical Neurology | 1 |
| Virology | 1 |
| Chemistry, Applied | 1 |
| Horticulture | 1 |
| Evolutionary Biology | 1 |
| Mineralogy | 1 |
| Cell Biology | 1 |
| Environmental Sciences | 1 |
| Mining & Mineral Processing | 1 |
| Developmental Biology | 1 |
| Nutrition & Dietetics | 1 |
| Scopus | #Pub |
|---|---|
| Molecular Biology | 6 |
| Microbiology | 5 |
| Genetics | 4 |
| Applied Microbiology And Biotechnology | 3 |
| Drug Discovery | 3 |
| Pharmacology | 3 |
| Chemistry (All) | 2 |
| Biotechnology | 2 |
| Immunology And Microbiology (Miscellaneous) | 2 |
| Cellular And Molecular Neuroscience | 1 |
| Plant Science | 1 |
| Physics And Astronomy (All) | 1 |
| Analytical Chemistry | 1 |
| Neurology | 1 |
| Molecular Medicine | 1 |
| Food Science | 1 |
| Ecology | 1 |
| Horticulture | 1 |
| SciELO | #Pub |
|---|---|
| Applied Social Sciences | 2 |
| Biological Sciences | 2 |
| Engineering | 2 |
| Exact And Earth Sciences | 2 |
| Publicaciones | Citas | ||||
|---|---|---|---|---|---|
| Total | Porcentaje | Total | Porcentaje | Representativas Cuartil (Mediana) | |
| Q1 | 18 | 31.0 % | 511 | 40.7 % | 23.0 |
| Q2 | 17 | 29.3 % | 471 | 37.5 % | 17 |
| Q3 | 16 | 27.6 % | 215 | 17.1 % | 9.5 |
| Q4 | 7 | 12.1 % | 59 | 4.7 % | 9 |